Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | BMY | AMGN | GILD | REGN |
| Company | Ascendis Pharma ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 143.30 | 49.16 | 272.14 | 67.09 | 905.66 |
| High | 146.94 | 49.47 | 274.08 | 67.68 | 912.74 |
| Low | 143.30 | 48.96 | 271.05 | 67.07 | 903.83 |
| Last | 146.44 | 49.18 | 273.80 | 67.25 | 904.66 |
| Change | +4.34 | +0.04 | +1.89 | +0.30 | +4.50 |
| % Change | +3.05% | +0.08% | +0.70% | +0.45% | +0.50% |
| Volume | 61,498 | 2,364,632 | 627,537 | 1,556,682 | 98,746 |
| 20-Day Average Volume | 293,021 | 10,606,728 | 2,121,961 | 6,147,276 | 430,124 |
| Previous Close | 142.10 | 49.14 | 271.91 | 66.95 | 900.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 147.25 | 50.56 | 271.99 | 69.35 | 929.02 |
| 20-Day Raw Stochastic | 42.80% | 23.63% | 46.23% | 17.06% | 16.80% |
| 20-Day Relative Strength | 50.14% | 42.90% | 48.72% | 34.11% | 38.62% |
| Weighted Alpha | +83.50 | -25.23 | +11.47 | -20.48 | +13.59 |
| Today's Opinion | 40% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 40% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 88% Buy | 24% Sell | 8% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.13% since 04/16/24 | +2.02% since 04/16/24 | +2.99% since 04/16/24 | -0.07% since 04/16/24 | +1.21% since 04/16/24 |
| Low | 137.78 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 891.46 on 04/19/24 |
| High | 146.77 on 04/23/24 | 49.56 on 04/22/24 | 274.08 on 04/23/24 | 67.68 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | +0.63% since 03/22/24 | -5.19% since 03/22/24 | -0.94% since 03/22/24 | -7.37% since 03/22/24 | -6.44% since 03/22/24 |
| Low | 137.78 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 156.84 on 04/10/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +6.91% since 01/23/24 | -1.76% since 01/23/24 | -11.73% since 01/23/24 | -15.37% since 01/23/24 | -5.20% since 01/23/24 |
| Low | 127.95 on 01/31/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 161.00 on 02/26/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +67.47% since 10/23/23 | -12.08% since 10/23/23 | +0.19% since 10/23/23 | -13.28% since 10/23/23 | +13.75% since 10/23/23 |
| Low | 85.38 on 10/25/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 161.00 on 02/26/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,273,630 | 99,594,944 | 145,845,984 | 83,357,904 | 98,803,360 |
| Shares Outstanding, K | 58,224 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 288,670,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -521,070,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 148,660,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -93,040,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.50 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.66 on 02/07/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 04/25/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.52 | 14.42 | 9.93 | 23.86 |